3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Recruiting
3
Sponsor Class
OTHER
3
Study Type
Observational
2
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
3
Other hematologic neoplasm
1
Gynecologic
1
Genitourinary
1
Conditions
Carcinoma, Hepatocellular
2
Neoplasms
1
Liver Neoplasms
1
Gastrointestinal Neoplasms
1
Interventions
Oxaliplatin
1004
Fluorouracil
800
Capecitabine
765
Gemcitabine
651
Leucovorin
559
Irinotecan
537
Bevacizumab
513
Radiotherapy
460
Cisplatin
441
Drug Therapy
298
Cetuximab
280
Surgical Procedures, Operative
229
Paclitaxel
228
S 1 (combination)
218
pembrolizumab
206
Docetaxel
199
130-nm albumin-bound paclitaxel
196
Nivolumab
193
sintilimab
191
Radiosurgery
190
lenvatinib
181
Folfox protocol
179
Sorafenib
178
Albumin-Bound Paclitaxel
173
apatinib
170
tislelizumab
161
camrelizumab
160
Neoadjuvant Therapy
158
Blood Specimen Collection
154
durvalumab
148
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
3 trials
Recent
Start date
Enrollment
OTHER
×
Glutamyl Aminopeptidase
×
Gastrointestinal
×
Clear all
NCT05441163
2025-06-24
ProActIF-01
Institut Curie
Phase NA
Recruiting
50 enrolled
NCT05713994
2025-03-25
CCGLC-001
Tongji Hospital
Recruiting
300 enrolled
NCT05717738
2024-06-13
CCGLC-008
Tongji Hospital
Recruiting
300 enrolled